First Time Loading...

Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 73.38 USD -0.03%
Updated: May 10, 2024
Section:
 

Wall Street
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 127.43 USD with a low forecast of 97.97 USD and a high forecast of 199.5 USD.

AXSM Lowest Forecast
Wall Street Target
97.97 USD
34% Upside
AXSM Average Forecast
Wall Street Target
127.43 USD
74% Upside
AXSM Highest Forecast
Wall Street Target
199.5 USD
172% Upside
Lowest
Price Target
97.97 USD
34% Upside
Average
Price Target
127.43 USD
74% Upside
Highest
Price Target
199.5 USD
172% Upside

AXSM Last Price Targets
Axsome Therapeutics Inc

The latest public price target was made on Apr 29, 2024 by Vikram Purohit from Morgan Stanley , who expects AXSM stock to rise by 57% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Vikram Purohit
Morgan Stanley
115 USD
Upside 57%
1 week ago
Apr 29, 2024
Morgan Stanley Upgrades Axsome Therapeutics (AXSM) to Overweight, 'attractive risk/reward heading into 2H24'
StreetInsider
Graig Suvannavejh
Mizuho Securities
109 USD
Upside 49%
1 month ago
Mar 28, 2024
Axsome Therapeutics (AXSM) PT Raised to $109 at Mizuho
StreetInsider
Joel Beatty
Robert W. Baird
108 USD
Upside 47%
1 month ago
Mar 18, 2024
Baird Starts Axsome Therapeutics (AXSM) at Outperform, 'we anticipate the sales trajectory will remain strong'
StreetInsider
Vikram Purohit
Morgan Stanley
Price Target 115 USD
Upside/Downside 57%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 109 USD
Upside/Downside 49%
View Source
Joel Beatty
Robert W. Baird
Price Target 108 USD
Upside/Downside 47%
View Source
Axsome Therapeutics Inc Competitors:
Price Targets
S
SDZ
Sandoz Group AG
10% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
19% Upside
PFE
Pfizer Inc
14% Upside
K
KILITCH
Kilitch Drugs (India) Ltd
45% Upside
S
SDZ
Sandoz Group AG
10% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
19% Upside
PFE
Pfizer Inc
14% Upside
K
KILITCH
Kilitch Drugs (India) Ltd
45% Upside
603229
Zhejiang Ausun Pharmaceutical Co Ltd
76% Upside
524731
Jenburkt Pharmaceuticals Ltd
32% Downside
VENUSREM
Venus Remedies Ltd
31% Upside
EOLS
Evolus Inc
80% Upside

Revenue
Forecast

Revenue Estimate
Axsome Therapeutics Inc

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 3 years is 61%.

N/A
Past Growth
61%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

See Also

Summary
AXSM intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXSM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXSM stock valuation using valuation multiples.
Wall Street Estimates
AXSM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXSM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXSM's stock price target?
Price Target
127.43 USD

According to Wall Street analysts, the average 1-year price target for AXSM is 127.43 USD with a low forecast of 97.97 USD and a high forecast of 199.5 USD.

What is Axsome Therapeutics Inc's Revenue forecast?
Projected CAGR
61%

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 3 years is 61%.

ALPHA SPREAD
Join more than 136,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.